Welcome to our dedicated page for Perceptive Capital Solutions SEC filings (Ticker: PCSC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Perceptive Capital Solutions Corp (PCSC) is a special purpose acquisition company in the Financial Services sector, listed on The Nasdaq Global Market under the ticker PCSC. It is described as a blank check company formed for the purpose of entering into a combination with one or more businesses or entities, with an intended focus on healthcare in the United States and other developed countries.
This SEC filings page is designed to help users review the regulatory record associated with PCSC’s SPAC activities. Although specific filings are not listed in the provided data, public communications indicate that PCSC’s securities were registered with the U.S. Securities and Exchange Commission in connection with its initial public offering of Class A ordinary shares. The registration statement for that offering was declared effective by the SEC, and the company notes that the offering was made only by means of a prospectus filed with the Commission.
In connection with its announced business combination with Freenome Holdings, Inc., PCSC has stated that it intends to file a registration statement on Form S-4 with the SEC. That filing is expected to include preliminary and definitive proxy statements for PCSC shareholders and a prospectus relating to the securities to be issued to Freenome’s stockholders. Additional information about the transaction is also expected to appear in a Current Report on Form 8-K filed by PCSC.
On this page, users can access PCSC’s historical and future SEC submissions, including registration statements, proxy materials and current reports that describe its SPAC structure, risk factors and the terms of its proposed business combination. AI-powered tools on the platform can assist in summarizing long-form documents, clarifying key sections in forms such as S-4 and 8-K, and highlighting information relevant to the evolution of PCSC’s capital structure and its transition to any combined company.
Freenome, Inc. reported that Perceptive Life Sciences Master Fund Ltd. acquired 5,500,000 shares of Common Stock on July 20, 2026 at $10.00 per share, in a grant/award-type acquisition. Following this transaction, the Master Fund’s reported Common Stock holdings total 10,871,847 shares. The securities are directly held by the Master Fund; Perceptive Advisors LLC, as investment manager, and Joseph Edelman, as managing member of the Advisor, report indirect pecuniary interests and each disclaims beneficial ownership beyond that. The Rule 10b5-1 trading plan checkbox was not marked for this transaction.
Freenome, Inc. reports that Perceptive Life Sciences Master Fund Ltd, Perceptive Advisors LLC and Joseph Edelman have filed an initial statement of beneficial ownership as 10% owners. The common stock reported corresponds to Legacy Freenome Series B, C, D and F preferred shares on an as-converted basis in connection with a business combination between Freenome Holdings, Inc. and Perceptive Capital Solutions Corp. under a Business Combination Agreement dated December 5, 2025. Perceptive Advisors and Mr. Edelman disclaim beneficial ownership beyond their indirect pecuniary interest.
Freenome, Inc. reported that former director Mark C. McKenna converted 30,000 Class B Ordinary Shares into 30,000 shares of Common Stock on July 20, 2026, in connection with the closing of its Business Combination under the Business Combination Agreement dated December 5, 2025 and amended July 20, 2026.
Freenome, Inc. reported that Perceptive Capital Solutions Holdings (the Sponsor) converted 2,066,250 Class B Ordinary Shares into the same number of shares of Common Stock on July 20, 2026 in connection with the closing of its business combination with Freenome Holdings, Inc.
The securities are held indirectly by the Sponsor, whose board, including Adam Stone and Michael Altman, has voting and investment discretion, resulting in 2,352,500 shares of Common Stock held indirectly after the conversion.
Freenome, Inc. reported that on July 20, 2026, in connection with the closing of its business combination with Freenome Holdings, Inc., Perceptive Capital Solutions Holdings, an entity whose board includes Michael Altman, converted 2,066,250 Class B Ordinary Shares into 2,066,250 shares of Common Stock. Following this one-for-one share-class conversion, Perceptive Capital Solutions Holdings indirectly held 2,352,500 shares of Common Stock.
RA Capital Management, L.P., together with Peter Kolchinsky, Rajeev Shah and affiliated funds, beneficially owns 15,367,270 shares of Freenome, Inc. common stock, representing 14.3% of the 107,446,814 shares outstanding as of the July 20, 2026 business combination closing.
The stake is held across RA Capital Healthcare Fund, L.P. (12,230,122 shares), several Nexus funds and a managed account. The investors received Freenome shares in the business combination for an aggregate prior equity investment of $218,999,969 and purchased additional PIPE shares for $52,553,760 at $10 per share. An investor rights agreement provides resale registration, demand and piggyback rights, while a lock-up restricts transfers for six months after closing. The position is for investment purposes, though the investors may adjust holdings and engage with management, and Kolchinsky serves as a director.
RA Capital Management, L.P. and affiliated investment funds reported indirect acquisitions of Freenome, Inc. common stock on July 20, 2026. Several blocks, including 6,561,711 shares, were received pursuant to a Business Combination with Old Freenome, while others, such as 4,918,411 shares, were acquired at $10.00 per share. The shares are held by RA Capital Healthcare Fund, the Nexus funds, and a separately managed account, with RA Capital as investment manager; Dr. Peter Kolchinsky and Mr. Rajeev Shah disclaim beneficial ownership beyond their respective pecuniary interests.
RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., Dr. Peter Kolchinsky and Mr. Rajeev Shah report indirect ownership of 750,000 shares of Freenome, Inc. common stock, held directly by the Fund as of July 20, 2026.
The Adviser acts as investment manager to the Fund, whose general partner is RA Capital Management GP, LLC. Each of the Adviser, the Adviser GP, the Fund, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership except to the extent of respective pecuniary interests.
Freenome, Inc. is being removed from listing and registration on the Nasdaq Stock Market LLC for its Class A Ordinary Shares under Section 12(b) of the Securities Exchange Act of 1934. Nasdaq certifies that both the exchange and the issuer have complied with the applicable rules for this voluntary withdrawal.
Perceptive Capital Solutions Corp held an extraordinary general meeting on July 15, 2026, where shareholders approved the Business Combination Proposal, Domestication Proposal, new governing documents, Nasdaq listing-related proposal, and new equity incentive and employee stock purchase plans tied to a Business Combination involving PCSC and Freenome.
The approvals made an adjournment vote unnecessary. The meeting had a quorum, with 5,645,461 Class A and 2,156,250 Class B ordinary shares represented, about 75.65% of voting power as of the June 12, 2026 record date. Total shares outstanding then were 10,313,492, including 8,157,242 Class A shares. PCSC notes that completing the Business Combination and related transactions remains subject to conditions and risks discussed in its proxy materials and SEC reports.